Toxicology & Epidemiological Kinetics

Bone Lead Burden & Lifelong Exposure Simulator

Based on The Washington Post investigative findings: "Lead poisoning is not a one-time event. The metal may remain in your blood for a few months after exposure, but 70 to 95 percent of what isn’t excreted is locked up in your bones, often for decades." As bone remodels during aging, stored lead leaches back into circulation, driving neurotoxicity and elevating dementia risk.

Peak Blood Lead 25.0 µg/dL Childhood acute marker
Bone Reservoir Burden 182.5 mg Cortical skeletal mass
Late Mobilization 4.8 µg/dL Remodeling release
Dementia Risk Factor 1.74× Late-life hazard ratio
Sequestration Status High Skeletal Sequestration Decadal reservoir lock
Parameters
Presets:
Pediatric peak blood concentration during acute exposure window
Age at primary environmental absorption (paint/leaded fuel)
Portion of non-excreted lead deposited into cortical hydroxyapatite
Annual skeletal turnover rate (accelerates with osteoporosis/andropause)
Decades elapsed since initial pediatric exposure episode
Decadal Toxicokinetics: Clearance vs. Skeletal Reservoir Live 50-Year Projection
Evidence Dossier: Bone Remodeling & Neurodegenerative Cascade

Hydroxyapatite Sequestration (70–95%)

Lead (Pb²⁺) mimics calcium (Ca²⁺) and substitutes into the crystalline matrix of cortical bone. While blood half-life is brief (~30 days), skeletal half-life spans 20 to 30 years. Bones act as an endogenous storage depot protecting acute organs initially, but preserving long-term poison.

Late-Life Endogenous Mobilization

During aging, menopause, fractures, or osteoporosis, osteoclasts resorb bone mineral. This unleashes sequestered lead back into the microvasculature, exposing the cerebral cortex and hippocampus to continuous low-grade oxidative insult decades after initial exposure.

Dementia & Cognitive Decline Link

Longitudinal epidemiology cited in The Washington Post connects cumulative lifetime bone lead (measured via K-shell X-ray fluorescence) with accelerated cognitive decline, elevated beta-amyloid aggregation, and increased hazard ratios for clinical dementia.

Validated Kinetic Model v2.4

Calibrated against multi-compartmental Rabinowitz & Leggett biokinetic models.

Enjoy this tool? Build your own with Super